Step-Down" Approach May Be Unnecessary
High-dose fluticasone versus low-doseflucticasone is no more effective in treatingasthma. A study, reported in Chest (January2005), found that starting individualswith moderate asthma on a high dose ofthe inhaled steroid and then steppingdown to a low dose provides no greaterbenefit than starting at a low fixed dose.
For the study, the researchers randomlyassigned 35 patients to begin inhaledfluticasone propionate at 1000 mcg perday and then to lower the dose to 200mcg per day, or to start treatment at afixed dose of 200 mcg.
The results of the study showed thatboth regimens lowered bronchial hyperresponsivenessand airway inflammation toa similar degree. Furthermore, 8 weeksafter stopping fluticasone, inflammationindicators stayed in the normal range in30% of the patients in both groups.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025